SHARE THIS VIDEO —
AstraZeneca says it should know before end of year if experimental vaccine will protect from COVID-19
AstraZeneca's chief executive Pascal Soriot said late-stage trials were suspended after a study subject fell ill in Britain. The person was reportedly suffering from neurological symptoms.